Thursday, April 29

4:30 pm – 6:00pm

Visits Virtual Booths

6:00 pm

Welcome and Introduction to the Meeting

Drs. Calnon and Wolinsky

Session 1. Striving for Equity in Management of the Leading Causes of Death in 2020: Cardiovascular Diseases and COViD-19”

6:10 pm

Keynote Lecture: Addressing Healthcare Disparities in Cardiovascular Disease

Clyde Yancy, MD, MSc

6:55 pm

Keynote Lecture: “COVID-19 Update – Equity and Impact on Disproportionately Affected Populations”

CDR Kristie E.N. Clarke, MD, MSCR

7:40 pm

Panel Discussion – Virtual presentation

8:00 pm

Adjourn

Friday, April 30

4:30 pm -6:00 pm

Visit Virtual Booths

Session 2. State of the Art of Cardiac Imaging in 2021

6:00 pm

Welcome and Key Points from Day 1

Drs. Calnon and Wolinsky

6:05 pm

Evolution of Evidence in Cardiac Testing

James Udelson, MD

6:50 pm

How do MPI and CTA live together in 2021?

Prem Soman, MD, PhD

7:35 pm

How will cardiac imaging evolve over the next 5 years?

Faculty and Participants

8:00 pm

Reception - Industry

8:30 pm

Adjourn

Saturday, May 1

8:00 am

Visit Exhibit Booths

Session 3: Cardiac SPECT – Optimizing Performance

Moderators: Dr. Bullock-Palmer

9:00 am

Welcome and Goals for Day 3

9:05 am

How to Recognize and Prevent Artifacts

James Case, PhD

9:25 am

Integrating Non-Perfusion Data

Rami Doukky, MD

9:45 am

Interactive cases – Getting the Most Out of a Not So Perfect Study

Drs. Bullock-Palmer + Doukky + Case

10:15 am

Break – Visit Exhibit Booths

Session 4: Cardiac PET in Real-World Practice

Moderator: Dr. Sanghani

10:30 am

Clinical Value of PET

Dennis Calnon, MD

10:50 am

Quality Control = Quality Performance

James Case, PhD

11:10 am

Guiding Management Decisions with MBF/MBFR – Interactive Case Studies

Marcelo Di Carli, MD

12:00

Break – Visit Exhibit Booths

Session 5: Image Guided Disease State Management in a Changing Healthcare Environment

Moderator: Dr. Calnon

12:30 pm

CAC and the Power of Zero; Can we use CAC for Symptomatic Patients?

Khurram Nasir, MD

1:00 pm

Looking Beyond Appropriate Use to Appropriateness in Clinical Practice

David Wolinsky, MD

1:20 pm

The Many Faces of Heart Failure and the Role of Cardiac Imaging

Saurabh Malhotra, MD

1:40 pm

Role of Myocardial Viability in Real World Practice

Rob Beanlands, MD

2:00 pm

Evaluating patients with Tc-99m PYP:  Don’t Prescribe the Wrong Drug Because of a Poor Test

David Wolinsky, MD

2:20 pm

Interactive Tc-99m PYP Cases

David Wolinsky, MD and Prem Soman, MD, PhD

3:00 pm

Break – Visit Exhibit Booths

Session 6: Expanding the Horizon in a Changing Healthcare Environment

Moderator: Renee Bullock-Palmer, MD

3:20 pm

Coronary Microvascular Disease: From Mystery to Reality

Rupa Sanghani, MD

3:40 pm

Cardiac Sarcoidosis: Clinical utility of FDG PET

Panithaya Chareonthaitawee, MD

4:00 pm

Challenging Cases in Nuclear Cardiology

Wael Jaber, MD

4:45 pm

Q&A

Sunday, May 2

8:00 am

Visit Virtual Booths

Session 7: Health Policy and Advocacy Efforts by ASNC

Moderator: Dennis Calnon, MD

8:30 am

Your ASNC at Work – Navigating Impediments to the Practice of Nuclear Cardiology

Drs. Wolinsky and Thompson

Session 8: Practical Dilemmas in Nuclear Cardiology – Using What you Have Learned

Moderators: Drs. Wolinsky and Calnon

9:15 am

Is the Test Normal, Borderline, or Mildly Abnormal? What are the Implications for How you Report the Study

Renee Bullock-Palmer, MD

9:30 am

The Patient Reaches Target Heart Rate at 1 Minute of Exercise Due to Severe Deconditioning and Anxiety: Is This an Adequate Stress for MPI?”  

Randy Thompson, MD

9:45 am

What Does it Mean if the Myocardial Blood Flow Reserve is Abnormal Because Resting MBF is Elevated? Should We Report Corrected MBFR or Peak Stress MBF?

Marcelo Di Carli, MD

10:00 am

If the Regadenoson Dose Infiltrates, Can the Dose Be Repeated as Soon as IV Access Is Achieved?

Dennis Calnon, MD

10:15 am

What if There is No Flow Augmentation With Vasodilator Stress?  What Do We Do?

Randy Thompson, MD

10:30 am

How Do I Manage a Grade 1 Tc-99m PYP Scan?  Biopsy?  Repeat the Test in A Year? Treat Empirically?

Jamie Bourque, MD

10:45 am

Break – Visit Virtual Booths

11:00 am

Ischemic Testing with MPI in Hypertrophic Cardiomyopathy:  Is There Value?

Prem Soman, MD, PhD

11:15 am

What to Do With the Patient Who Can’t Lay Flat or Stay Still

Renee Bullock-Palmer, MD

11:30 am

Should Tc-99m PYP Be Done Routinely Pre-TAVR? If Tc-99m PYP is Positive, Should We Proceed With TAVR?

David Wolinsky, MD

11:45 am

Stress-first SPECT Shows a Clear Defect in a Patient with No Prior CAD;  Get the Resting Image or Straight to the Cath Lab?

Dennis Calnon, MD

12:00 pm

New Onset Systolic Dysfunction: Can Ischemic Cardiomyopathy Be Excluded With Cardiac Imaging?  Do All Patients Need A Catheterization?

Rupa Sanghani, MD

12:15 pm

Is CTA the Best Test for CAD Assessment with LBBB?

Renee Bullock-Palmer, MD

12:30 pm

The Stress EKG is Markedly Abnormal, Perfusion Scan is Normal, and the Patient is Asymptomatic – What Recommendation Do You Give to the Referring Doctor?

Jamie Bourque, MD

12:45 pm

Patient has LBBB and Referred for SPECT MPI but Reports Recent Hospitalization for Seizures

Renee Bullock-Palmer, MD

1:00

Closing Remarks and Adjourn